These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 24008372)
1. Expression levels and significance of nuclear factor-κB and epidermal growth factor receptor in hepatolithiasis associated with intrahepatic cholangiocarcinoma. Zhou Q; Gong Y; Huang F; Lin Q; Zeng B; Li Z; Chen R Dig Surg; 2013; 30(4-6):309-16. PubMed ID: 24008372 [TBL] [Abstract][Full Text] [Related]
2. Comparison of concomitant and subsequent cholangiocarcinomas associated with hepatolithiasis: Clinical implications. Lin CC; Lin PY; Chen YL World J Gastroenterol; 2013 Jan; 19(3):375-80. PubMed ID: 23372360 [TBL] [Abstract][Full Text] [Related]
3. Characterization of EGFR family gene aberrations in cholangiocarcinoma. Yang X; Wang W; Wang C; Wang L; Yang M; Qi M; Su H; Sun X; Liu Z; Zhang J; Qin X; Han B Oncol Rep; 2014 Aug; 32(2):700-8. PubMed ID: 24927194 [TBL] [Abstract][Full Text] [Related]
4. Clinicopathological analysis of colorectal cancer liver metastasis and intrahepatic cholangiocarcinoma: are they just apples and oranges? Chiu CT; Chiang JM; Yeh TS; Tseng JH; Chen TC; Jan YY; Chen MF Dig Liver Dis; 2008 Sep; 40(9):749-54. PubMed ID: 18329969 [TBL] [Abstract][Full Text] [Related]
5. c-erbB-2 and c-Met expression relates to cholangiocarcinogenesis and progression of intrahepatic cholangiocarcinoma. Aishima SI; Taguchi KI; Sugimachi K; Shimada M; Sugimachi K; Tsuneyoshi M Histopathology; 2002 Mar; 40(3):269-78. PubMed ID: 11895493 [TBL] [Abstract][Full Text] [Related]
6. Prognostic Risk Factors Associated with Recurrence and Metastasis After Radical Resection in Patients with Hepatolithiasis Complicated by Intrahepatic Cholangiocarcinoma. Zhu Y; Zhu Y; Cai F; Zhao J; Liu F Cell Biochem Biophys; 2015 Nov; 73(2):455-460. PubMed ID: 27352338 [TBL] [Abstract][Full Text] [Related]
7. [Expression of epidermal growth factor receptor, ErbB2 and matrix metalloproteinase-9 in hepatolithiasis and cholangiocarcinoma]. Kim HJ; Kim JS; Kang CD; Lee SJ; Kim JY; Yeon JE; Park JJ; Shim JJ; Byun KS; Bak YT; Lee CH Korean J Gastroenterol; 2005 Jan; 45(1):52-9. PubMed ID: 15665568 [TBL] [Abstract][Full Text] [Related]
8. Characterization of intrahepatic cholangiocarcinoma of the intraductal growth-type and its precursor lesions. Yeh TS; Tseng JH; Chen TC; Liu NJ; Chiu CT; Jan YY; Chen MF Hepatology; 2005 Sep; 42(3):657-64. PubMed ID: 16116640 [TBL] [Abstract][Full Text] [Related]
9. Outcomes of hepatic resection for hepatolithiasis. Uenishi T; Hamba H; Takemura S; Oba K; Ogawa M; Yamamoto T; Tanaka S; Kubo S Am J Surg; 2009 Aug; 198(2):199-202. PubMed ID: 19249730 [TBL] [Abstract][Full Text] [Related]
10. SOX4 is associated with poor prognosis in cholangiocarcinoma. Wang W; Zhang J; Zhan X; Lin T; Yang M; Hu J; Han B; Hu S Biochem Biophys Res Commun; 2014 Sep; 452(3):614-21. PubMed ID: 25181339 [TBL] [Abstract][Full Text] [Related]
11. Prognosis of Intrahepatic Cholangiocarcinomas with HBV Infection is Better than Those with Hepatolithiasis After R0 Liver Resection: A Propensity Score Matching Analysis. Wang Q; Li J; Lei Z; Wu D; Si A; Wang K; Wang Y; Wan X; Lau WY; Shen F Ann Surg Oncol; 2017 Jun; 24(6):1579-1587. PubMed ID: 28058554 [TBL] [Abstract][Full Text] [Related]
12. Precancerous Lesions and Liver Atrophy as Risk Factors for Hepatolithiasis-Related Death after Liver Resection for Hepatolithiasis. Miyazaki T; Shinkawa H; Takemura S; Tanaka S; Amano R; Kimura K; Ohira G; Nishio K; Kinoshita M; Tsuchi J; Ishihara A; Eguchi S; Shirai D; Yamamoto T; Wakasa K; Kawada N; Kubo S Asian Pac J Cancer Prev; 2020 Dec; 21(12):3647-3654. PubMed ID: 33369464 [TBL] [Abstract][Full Text] [Related]
13. EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition. Clapéron A; Mergey M; Nguyen Ho-Bouldoires TH; Vignjevic D; Wendum D; Chrétien Y; Merabtene F; Frazao A; Paradis V; Housset C; Guedj N; Fouassier L J Hepatol; 2014 Aug; 61(2):325-32. PubMed ID: 24704591 [TBL] [Abstract][Full Text] [Related]
14. Different expression of glucose transporters in the progression of intrahepatic cholangiocarcinoma. Kubo Y; Aishima S; Tanaka Y; Shindo K; Mizuuchi Y; Abe K; Shirabe K; Maehara Y; Honda H; Oda Y Hum Pathol; 2014 Aug; 45(8):1610-7. PubMed ID: 24824030 [TBL] [Abstract][Full Text] [Related]
15. Hepatic myofibroblasts promote the progression of human cholangiocarcinoma through activation of epidermal growth factor receptor. Clapéron A; Mergey M; Aoudjehane L; Ho-Bouldoires TH; Wendum D; Prignon A; Merabtene F; Firrincieli D; Desbois-Mouthon C; Scatton O; Conti F; Housset C; Fouassier L Hepatology; 2013 Dec; 58(6):2001-11. PubMed ID: 23787814 [TBL] [Abstract][Full Text] [Related]
16. Increasing expression of gastrointestinal phenotypes and p53 along with histologic progression of intraductal papillary neoplasia of the liver. Shimonishi T; Zen Y; Chen TC; Chen MF; Jan YY; Yeh TS; Nimura Y; Nakanuma Y Hum Pathol; 2002 May; 33(5):503-11. PubMed ID: 12094375 [TBL] [Abstract][Full Text] [Related]
17. In situ nucleic acid detection of human telomerase in intrahepatic cholangiocarcinoma and its preneoplastic lesion. Ozaki S; Harada K; Sanzen T; Watanabe K; Tsui W; Nakanuma Y Hepatology; 1999 Oct; 30(4):914-9. PubMed ID: 10498642 [TBL] [Abstract][Full Text] [Related]
18. Identification of prognostic factors and the impact of palliative resection on survival of patients with stage IV hepatolithiasis-associated intrahepatic cholangiocarcinoma. Zhang GW; Lin JH; Qian JP; Zhou J J Surg Oncol; 2014 Apr; 109(5):494-9. PubMed ID: 24310342 [TBL] [Abstract][Full Text] [Related]
19. The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Choi SB; Kim KS; Choi JY; Park SW; Choi JS; Lee WJ; Chung JB Ann Surg Oncol; 2009 Nov; 16(11):3048-56. PubMed ID: 19626372 [TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma. Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]